MARKET

NOTV

NOTV

Inotiv Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.23
+0.54
+3.68%
Opening 12:41 05/26 EDT
OPEN
14.72
PREV CLOSE
14.69
HIGH
15.36
LOW
14.63
VOLUME
129.17K
TURNOVER
1.35M
52 WEEK HIGH
60.66
52 WEEK LOW
11.25
MARKET CAP
388.60M
P/E (TTM)
-4.7155
1D
5D
1M
3M
1Y
5Y
58 Biggest Movers From Yesterday
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
Benzinga · 2d ago
Mid-Afternoon Market Update: Nasdaq Gains 150 Points; Copper Up 1.5%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 600 points on Monday.
Benzinga · 2d ago
HIVE, XIN and NEON among mid-day movers
Gainers: Lixiang Education Holding (LXEH) +62%. GeoVax Labs (GOVX) +50%. Sonder Holdings (SOND) +30%. O2Micro International (OIIM) +30%. Evolving Systems (OTC:EVOL) +28%. GoldMining (GLDG) +27%. Neonode (NEON) +24%. Mesa Royalty
Seekingalpha · 2d ago
Mid-Day Market Update: Dow Rises Over 600 Points; O2Micro International Shares Surge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 600 points on Monday.
Benzinga · 3d ago
30 Stocks Moving In Monday's Mid-Day Session
Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.
Benzinga · 3d ago
Inotiv Says US Department of Justice Files Complaint for Alleged Animal Welfare Violations; Shares Plunge
MT Newswires · 3d ago
BRIEF-Inotiv Says U.S. Department Of Justice Executed A Search And Seizure Warrant On Cumberland, Virginia Facility
reuters.com · 5d ago
48 Stocks Moving In Tuesday's Mid-Day Session
Gainers Okyo Pharma Ltd. ADR (NASDAQ: OKYO) gained 30% to $5.20 as the company priced its IPO at $4 per ADS.
Benzinga · 05/17 16:00
More
No Data
Learn about the latest financial forecast of NOTV. Analyze the recent business situations of Inotiv Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average NOTV stock price target is 69.50 with a high estimate of 75.00 and a low estimate of 64.00.
High75.00
Average69.50
Low64.00
Current 15.23
EPS
Actual
Estimate
-3.14-2.36-1.57-0.79
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Institutional Holdings
Institutions: 109
Institutional Holdings: 14.11M
% Owned: 55.30%
Shares Outstanding: 25.52M
TypeInstitutionsShares
Increased
34
2.38M
New
28
4.57M
Decreased
32
1.18M
Sold Out
15
304.21K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.21%
Pharmaceuticals & Medical Research
+0.18%
Key Executives
Non-Executive Chairman/Independent Director
Gregory Davis
President/Chief Executive Officer/Director
Robert Leasure
Chief Financial Officer/Vice President - Finance/IR Contact Officer
Beth Taylor
Chief Operating Officer
John Beattie
Chief Operating Officer
James Harkness
Chief Human Resource Officer
William Pitchford
Executive Vice President
Adrian Hardy
Senior Vice President
Philip Downing
General Counsel/Secretary
Mark Bibi
Other/Director
John Sagartz
Other
Michael Garrett
Independent Director
Nigel Brown
Independent Director
Scott Cragg
Independent Director
Richard Johnson
Independent Director
R. Matthew Neff
No Data
No Data
About NOTV
Inotiv, Inc. is an international contract research company that is focused on providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates through two segments, including Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing. The Research Products segment offers two principal product lines, including analytical products and in vivo sampling products. Analytical products consist of liquid chromatographic and electrochemical instruments with associated accessories. In vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments.

Webull offers kinds of Inotiv Inc stock information, including NASDAQ:NOTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NOTV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NOTV stock methods without spending real money on the virtual paper trading platform.